Compare
5 stocks, side by sideRelative performance · rebased to 100
KNSAINDVRGCAMRXLQDA
| KNSAKiniksa Pharmaceuticals International, plc | INDVIndivior Pharmaceuticals, Inc. | RGCRegencell Bioscience Holdings Limited | AMRXAmneal Pharmaceuticals, Inc. | LQDALiquidia Corporation | |
|---|---|---|---|---|---|
| Smart Score | 6/10 | 5/10 | 1/10 | 4/10 | 5/10 |
| Price | $77.16 | $34.32 | $6.81 | $17.06 | $67.65 |
| 1 month | +0.88% | -11% | +25% | -5.6% | -24% |
| 1 year | +129% | +47% | -49% | +84% | +144% |
| 5 year | +520% | +186% | +2835% | +238% | +2767% |
| P/E (TTM) | 84.8 | 17.6 | -2.0 | 46.1 | 397.9 |
| P/E vs sector | +184% | -41% | - | +54% | +1232% |
| Market cap | $4.4B | $4.9B | $3.7B | $5.5B | $6.8B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.